In-house Products
SK bioscience develops vaccines with its innovative technology and produces them under a strict quality control system.
WHO PQ prequalified typhoid conjugate vaccine
SKY Typhoid Multi Inj.
(Thyphoid purified Vi Polysaccharide Conjugated to Diphtheria toxoid vaccine)
![SKY Typhoid Multi Inj. image](/ilb/image.php?i=product_thum_20240312160555.png&g=p1)
The first Korean-developed COVID-19 Vaccine
SKYCovione™
(SARS-CoV-2, Surface Antigen (Recombinant DNA))
![SKYCovione™ image](/ilb/image.php?i=product_thum_20220811151035.png&g=p1)
the world’s first-developed quadrivalent cell culture-___base___d influenza vaccine
SKYCellflu® Quadrivalent Prefilled Syringe
(cell culture-___base___d influenza vaccine)
![SKYCellflu® Quadrivalent Prefilled Syringe image](/ilb/image.php?i=product_thum_20210219183907.png&g=p1)
![SKYZoster® image](/ilb/image.php?i=product_thum_20230221164806.png&g=p1)
The WHO PQ certification obtained varicella vaccine
SKYVaricella®
(Live Attenuated Vaccine)
![SKYVaricella® image](/ilb/image.php?i=product_thum_20210219195228.png&g=p1)